SABRIL (vigabatrin) is a prescription medicine made use of with other therapies in adults and youngsters 2 years of age and older with refractory complex partial seizures (CPS) who have not responded all right to numerous other treatments and if the feasible advantages outweigh the threat of vision loss.
It is recommended that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and at least every 3 months throughout therapy until SABRIL is stopped. If you or your child have any side effect that bothers you or that does not go away, inform your medical care carrier.
Inform your doctor if you are expectant or intend to get expectant. If vision screening can not be done, your healthcare provider might proceed prescribing SABRIL, however will not have the ability to expect any vision loss. If vision examinations are refrained from doing regularly, your healthcare provider may quit recommending SABRIL for you (or your child).